PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -31.2% | 3,554 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $16,000 | -5.9% | 3,554 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | -29.2% | 3,554 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | -4.0% | 3,554 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $25,000 | +13.6% | 3,554 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $22,000 | +15.8% | 3,554 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | +72.7% | 3,554 | +71.8% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +57.1% | 2,069 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -12.5% | 2,069 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | -11.1% | 2,069 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | +12.5% | 2,069 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -27.3% | 2,069 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $11,000 | 0.0% | 2,069 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | -45.0% | 2,069 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $20,000 | -4.8% | 2,069 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $21,000 | -22.2% | 2,069 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $27,000 | -27.0% | 2,069 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $37,000 | -36.2% | 2,069 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $58,000 | +16.0% | 2,069 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $50,000 | +66.7% | 2,069 | +30.8% | 0.00% | +100.0% |
| Q1 2017 | $30,000 | – | 1,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |